Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma
Evaluating personalized MRD provided crucial prognostic insights into recurrence-free survival and overall survival. It efficiently identified patients at high risk of recurrence, even among those initially perceived as low-risk cases. See related commentary by Pinato et al., p. 955.
Authors
- Haoran Tang (ORCID: https://orcid.org/0009-0007-1805-0101)
- Jie Hu (ORCID: https://orcid.org/0000-0003-3518-6477)
- Jin-Peng Tan
- Shidong Jia (ORCID: https://orcid.org/0000-0001-5854-819X)
- Jia Fan (ORCID: https://orcid.org/0000-0001-5158-629X)
- Jian Zhou (ORCID: https://orcid.org/0000-0002-2118-1117)
- Xiangyu Zhang (ORCID: https://orcid.org/0000-0003-0170-0837)
- Ying Xu (ORCID: https://orcid.org/0009-0001-9505-9202)
- Cancan Jia
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Shanghai Medical Information Center (CN)
- Ministry of Education (SA)
- Shanghai Cancer Institute (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Ministry of Education (ET)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-1897
- Citations
- 9
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.33